Bessemer Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19K Buy
67
+8
+14% +$2.3K ﹤0.01% 1939
2025
Q4
$18K Buy
59
+16
+37% +$4.99K ﹤0.01% 1910
2025
Q3
$12K Buy
43
+34
+378% +$9.25K ﹤0.01% 1875
2025
Q2
$2K Sell
9
-25
-74% -$5.91K ﹤0.01% 2183
2025
Q1
$8K Sell
34
-92
-73% -$27.7K ﹤0.01% 1843
2024
Q4
$42K Buy
126
+17
+16% +$5.77K ﹤0.01% 1318
2024
Q3
$36K Buy
109
+89
+445% +$28.3K ﹤0.01% 1415
2024
Q2
$5K Buy
20
+9
+82% +$2.62K ﹤0.01% 1676
2024
Q1
$4K Buy
11
+6
+120% +$1.97K ﹤0.01% 1753
2023
Q4
$2K Sell
5
-353
-99% -$111K ﹤0.01% 2007
2023
Q3
$128K Sell
358
-21
-6% -$8.1K ﹤0.01% 1129
2023
Q2
$144K Sell
379
-107
-22% -$43.5K ﹤0.01% 1131
2023
Q1
$232K Sell
486
-55
-10% -$25.7K ﹤0.01% 874
2022
Q4
$227K Buy
541
+3
+0.6% +$1.21K ﹤0.01% 863
2022
Q3
$225K Buy
538
+43
+9% +$21.4K ﹤0.01% 870
2022
Q2
$245K Sell
495
-1,050
-68% -$547K ﹤0.01% 844
2022
Q1
$870K Buy
1,545
+391
+34% +$236K ﹤0.01% 506
2021
Q4
$872K Buy
1,154
+231
+25% +$173K ﹤0.01% 494
2021
Q3
$688K Buy
923
+30
+3% +$22.5K ﹤0.01% 489
2021
Q2
$575K Sell
893
-46
-5% -$28K ﹤0.01% 534
2021
Q1
$536K Sell
939
-762
-45% -$451K ﹤0.01% 528
2020
Q4
$992K Buy
1,701
+706
+71% +$402K ﹤0.01% 401
2020
Q3
$513K Sell
995
-1,675
-63% -$848K ﹤0.01% 500
2020
Q2
$1.21M Buy
2,670
+2,220
+493% +$980K ﹤0.01% 678
2020
Q1
$158K Buy
450
+374
+492% +$138K ﹤0.01% 1047
2019
Q4
$28K Buy
76
+44
+138% +$15.5K ﹤0.01% 1332
2019
Q3
$11K Buy
+32
New +$10.4K ﹤0.01% 1464
2019
Q1
Sell
-18
Closed -$4K 1771
2018
Q4
$4K Buy
+18
New +$4.83K ﹤0.01% 1809
2017
Q1
Sell
-39
Closed -$7K 1751
2016
Q4
$7K Hold
39
﹤0.01% 1681
2016
Q3
$6K Hold
39
﹤0.01% 1603
2016
Q2
$6K Sell
39
-5
-11% -$713 ﹤0.01% 1139
2016
Q1
$6K Buy
44
+24
+120% +$3.15K ﹤0.01% 1215
2015
Q4
$3K Hold
20
﹤0.01% 1446
2015
Q3
$3K Buy
+20
New +$2.88K ﹤0.01% 1407
2014
Q1
Sell
-25
Closed -$3K 1301
2013
Q4
$3K Buy
+25
New +$3.05K ﹤0.01% 1226
2013
Q3
Sell
-8
Closed -$1K 1244
2013
Q2
$1K Buy
+8
New +$938 ﹤0.01% 1286

Other funds holding BIO